Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr;7(3):318-321.
doi: 10.6004/jadpro.2016.7.3.15. Epub 2016 Apr 1.

Risk Stratification in Multiple Myeloma: Putting the Pieces Together

Angela Mayo  1 , Craig Reeder  1
Affiliations
Review

Risk Stratification in Multiple Myeloma: Putting the Pieces Together

Angela Mayo et al. J Adv Pract Oncol. 2016 Apr.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
mSMART: Off-study transplant eligible. Information from Dispenzieri et al. (2007); Kumar et al. (2009); Mikhael et al. (2013).
See this image and copyright information in PMC

References

    1. Dispenzieri Angela, Rajkumar S Vincent, Gertz Morie A, Fonseca Rafael, Lacy Martha Q, Bergsagel P Leif, Kyle Robert A, Greipp Philip R, Witzig Thomas E, Reeder Craig B, Lust John A, Russell Stephen J, Hayman Suzanne R, Roy Vivek, Kumar Shaji, Zeldenrust Steven R, Dalton Robert J, Stewart A Keith. Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement. Mayo Clinic proceedings. 2007;82:323–341. - PubMed
    1. Greipp Philip R, San Miguel Jesus, Durie Brian G M, Crowley John J, Barlogie Bart, Bladé Joan, Boccadoro Mario, Child J Anthony, Avet-Loiseau Herve, Harousseau Jean-Luc, Kyle Robert A, Lahuerta Juan J, Ludwig Heinz, Morgan Gareth, Powles Raymond, Shimizu Kazuyuki, Shustik Chaim, Sonneveld Pieter, Tosi Patrizia, Turesson Ingemar, Westin Jan. International staging system for multiple myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23:3412–3420. - PubMed
    1. Kumar Shaji K, Mikhael Joseph R, Buadi Francis K, Dingli David, Dispenzieri Angela, Fonseca Rafael, Gertz Morie A, Greipp Philip R, Hayman Suzanne R, Kyle Robert A, Lacy Martha Q, Lust John A, Reeder Craig B, Roy Vivek, Russell Stephen J, Short Kristen E Detweiler, Stewart A Keith, Witzig Thomas E, Zeldenrust Steven R, Dalton Robert J, Rajkumar S Vincent, Bergsagel P Leif. Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines. Mayo Clinic proceedings. 2009;84:1095–1110. - PMC - PubMed
    1. Mikhael Joseph R, Dingli David, Roy Vivek, Reeder Craig B, Buadi Francis K, Hayman Suzanne R, Dispenzieri Angela, Fonseca Rafael, Sher Taimur, Kyle Robert A, Lin Yi, Russell Stephen J, Kumar Shaji, Bergsagel P Leif, Zeldenrust Steven R, Leung Nelson, Drake Matthew T, Kapoor Prashant, Ansell Stephen M, Witzig Thomas E, Lust John A, Dalton Robert J, Gertz Morie A, Stewart A Keith, Stewart Keith, Rajkumar S Vincent, Chanan-Khan Asher, Lacy Martha Q. Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013. Mayo Clinic proceedings. 2013;88:360–376. - PubMed
    1. Reeder Craig B, Reece Donna E, Kukreti Vishal, Mikhael Joseph R, Chen Christine, Trudel Suzanne, Laumann Kristina, Vohra Harjot, Fonseca Rafael, Bergsagel P Leif, Leis Jose F, Tiedemann Rodger, Stewart A Keith. Long-term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma. British journal of haematology. 2014;167:563–565. - PubMed

LinkOut - more resources